期刊文献+

肝内胆管细胞癌超声造影增强模式探讨 被引量:3

The analysis of dynamic enhancement pattern of intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound
下载PDF
导出
摘要 目的分析肝内胆管细胞癌(ICC)的超声造影增强模式,探讨其诊断价值。方法38例ICC患者,共38个病灶,注射超声造影剂SonoVue后分析病灶增强水平与增强方式。结果ICC病灶直径1.7-9.6cm,平均(5.6±2.2)cm。动脉相增强模式:均匀高增强5个,不均匀高增强10个,均匀低增强1个,不均匀低增强13个,环状增强6个,部分增强2个,均匀等增强1个。门脉相:低增强36个,等增强2个。延迟相:38个均表现低增强。14个病灶在注射造影剂45s内开始消退,22个在45~120S消退,2个在120S后消退。结论ICC超声造影表现为动脉相多种增强模式,与病灶大小有一定相关性。 Objective To evaluate the value of contrast-enhanced ultrasound (CEUS) in the diagnosis of intrahepatic cholangiocarcinomas (ICC) and analyze their dynamic enhancement patterns. Methods The enhancement levels and patterns of 38 lesions in 38 patients with ICC who had undergone preoperative CEUS were retrospectively analyzed. Results The diameter of ICC lesions were 1.7-9.6 cm,the average diameter was (5.6_+2.2)cm. Seven patterns were shown during the arterial phase including 5 lesions of homogeneous hyperenhancement, 10 lesions of heterogeneous hyperenhancement, 1 lesion of homogeneous hypoenhancement, 13 lesions of heterogeneous hypoenhancement, 6 lesions of peripheral rim-like enhancement, 2 lesions of partially enhancement and 1 lesion of homogeneous isoenhancement. During the portal phase, 36 lesions were hypoenhanced and 2 lesions were isoenhanced. During the late phase, hypoenhancement was observed in all lesions. It appeared washout during 45 s in 14 lesions,between 45-120 s in 22 lesions and after 120 s in 2 lesions. Conclusion ICC may display a variety of patterns in the arterial phase and hypoenhaneement in the portal phase using CEUS. The enhancement patterns of ICC are correlated with tumor sizes.
出处 《临床超声医学杂志》 2013年第11期762-765,共4页 Journal of Clinical Ultrasound in Medicine
关键词 超声检查 造影剂 肝内胆管细胞癌 Ultrasonography Contrast agent Intrahepatic cholangiocarcinoma
  • 相关文献

参考文献19

  • 1Pouhsides GA, Zhu AX, Choti MA, et al. Intrahepatic cholangiocarcinoma. Surg Clin North Am, 2010, 90 (4) : 817-837.
  • 2Tucek S, Tomasek J, Hal a mkova J, et al. Bile duct malignancies. Klin Onkol, 2010, 23 (4): 231-241.
  • 3Blechacz B, Gores GJ. Cholangiocarcinoma:advances in pathogenesis, diagnosis, and treatment. Hepatology, 2008, 48 ( 1 ) : 308-321.
  • 4Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinorna: consensus document. Gut, 2002, 51 (suppl 6) : 1-9.
  • 5Slattery JM, Sahani DV. What is the current state-d-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist, 2006, 11 (8) :913-922.
  • 6唐小乔,仇毓东,张炜炜,孔文韬,周建新,丁义涛.超声及增强CT在肝内胆管细胞癌诊断中的应用[J].肝胆外科杂志,2010,18(5):335-337. 被引量:15
  • 7毛枫,王文平,李超伦,黄备建,袁海霞,丁红.彩色多普勒超声诊断周围型肝内胆管细胞癌的价值[J].中华肝胆外科杂志,2012,18(10):750-752. 被引量:8
  • 8Claudon M, Cosgrove D, Albrecht T, et al.Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) -update 2008,Ultrasehall Med, 2008,29( 1 ) : 28-44.
  • 9Xu HX, Lu MD, Liu GJ, et al.Imaging of peripheral cholangiocareinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experienee.J Uhrasound Med, 2006, 25 ( 1 ) : 23-33.
  • 10Chen LD,Xu HX,Xie XY,et al.Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol, 2008, 81 (971 ) : 881-889.

二级参考文献18

  • 1Okuda K, Kubo Y, et al. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer,1977,39( 1 ) :232 -46.
  • 2Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol, 2003,181 (3) :819 -27.
  • 3Khan SA, Davidson BR, et al; British Society of Gastroenterology. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut,2002,51 (6) :VI1 -9.
  • 4Chen MF. Peripheral cholangiocarcinoma (cholangiocellular carcinoma) : clinical features, diagnosis and treatment. J Gastroenterol Hepatol,1999,14(12) :1144 -9.
  • 5Miura F, Okazumi S, et al. Hemodynamics of intrahepatic cholangiocarcinoma : evaluation with single-level dynamic CT during hepatic arteriography. Abdom Imaging, 2004,29 ( 4 ) :467 - 71.
  • 6Xu HX, Lu MD, et al. Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience[J]. J Ultrasound Med,2006,25( 1 ) :23 -33.
  • 7Klein D, Jenett M, et al. Quantitative dynamic contrast-enhanced sonography of hepatic tumors. Eur Radiol, 2004,14 ( 6 ) : 1082 - 91.
  • 8Lim JH, Park CK. Pathology of cholangiocarcinoma. Abdom Imaging, 2004,29(5) :540 -7.
  • 9Dietrich CF. Characterisation of focal liver lesions with contrast enhanced ultrasonography. Eur J Radial,2004,51 Suppl : S9 - 17.
  • 10Martin R,Jamagin W. Intrahepatic cholangiocarcinoma. Cur rent management[J]. Minvera Chir, 2003,58:469-478.

共引文献20

同被引文献23

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部